CI

CI

USD

The Cigna Group Common Stock

$264.660+6.960 (2.701%)

वास्तविक समय मूल्य

Healthcare
Healthcare Plans
संयुक्त राज्य अमेरिका

मूल्य चार्ट

Loading Chart...

मुख्य मीट्रिक्स

बाजार मीट्रिक्स
कंपनी के मौलिक सिद्धांत
ट्रेडिंग आँकड़े

बाजार मीट्रिक्स

खुलना

$257.700

उच्च

$264.800

कम

$256.000

मात्रा

3.20M

कंपनी के मौलिक सिद्धांत

बाजार पूंजीकरण

70.7B

उद्योग

Healthcare Plans

देश

United States

ट्रेडिंग आँकड़े

औसत मात्रा

1.74M

एक्सचेंज

NYQ

मुद्रा

USD

52-सप्ताह रेंज

कम $239.51वर्तमान $264.660उच्च $350

AI विश्लेषण रिपोर्ट

अंतिम अपडेट: 3 नव॰ 2025
AI-जनितडेटा स्रोत: Yahoo Finance, Bloomberg, SEC

Cigna (CI) Stock Analysis: Finding Opportunity in Recent Turmoil

What Happened to Cigna's Stock?

Cigna took a serious hit recently. On October 30th, shares plunged 18% to $247.10 on massive volume - nearly 5.5 times their average trading activity. The selling continued the next day, dropping the stock to $244.41. This puts CI dangerously close to its 52-week low of $240.67.

What's puzzling is this crash happened despite generally positive news. The company beat Q3 earnings estimates, Goldman Sachs just initiated coverage with a strong Buy rating and $370 price target (that's 50% above current levels), and they announced meaningful initiatives to reduce medication costs for Americans.

Reading Between the Price Lines

Let's unpack what's really happening with Cigna's chart:

  • The Setup: Through most of August and September, CI built a solid upward trend, climbing from $260 to over $310
  • The Breakdown: After peaking near $315, the stock drifted lower through October
  • The Crash: That October 30th drop was no ordinary correction - it was a full-blown panic sell-off

Here's what stands out: the volume spike on October 30th wasn't normal distribution. When volume jumps that high during a sharp decline, it usually means big institutional players are exiting positions all at once. The good news? The selling pressure appears exhausted - the follow-through day on October 31st showed much weaker volume.

Why This Might Be Your Entry Window

Three compelling reasons suggest the worst may be over:

  1. Technical Signals Flashing Green: The stock now sits right at its support level ($244.33). When prices bounce off support with conviction, it often marks a turning point. Right now, the distance between current price and support is practically nonexistent - meaning we're at the make-or-break point.

  2. Goldman's Confidence: Their $370 price target isn't some random number. At current levels, that represents serious upside potential. What's interesting is they're not alone - 24 analysts maintain strong buy ratings.

  3. The News/Price Disconnect: Positive earnings, strategic initiatives, and dividend stability shouldn't result in an 18% single-day drop. This mismatch creates what traders call "mispricing" - a temporary gap between actual value and market price

संबंधित समाचार

Analyst Upgrades

Analysts Lower Cigna Targets As PBM Segment Guidance Surprises Market

Cigna expects 2026–2027 margin pressure from its new rebate-free PBM model as major clients renew at lower margins, prompting analyst target cuts.

और देखें
Analysts Lower Cigna Targets As PBM Segment Guidance Surprises Market
Analyst Upgrades

TD Cowen Maintains Buy on Cigna Group, Lowers Price Target to $333

TD Cowen analyst Charles Rhyee maintains Cigna Group with a Buy and lowers the price target from $387 to $333.

और देखें
TD Cowen Maintains Buy on Cigna Group, Lowers Price Target to $333
Analyst Upgrades

Goldman Sachs Maintains Buy on Cigna Group, Lowers Price Target to $330

Goldman Sachs analyst Scott Fidel maintains Cigna Group with a Buy and lowers the price target from $370 to $330.

और देखें
Goldman Sachs Maintains Buy on Cigna Group, Lowers Price Target to $330
Analyst Upgrades

JP Morgan Maintains Overweight on Cigna Group, Lowers Price Target to $375

JP Morgan analyst Lisa Gill maintains Cigna Group with a Overweight and lowers the price target from $428 to $375.

और देखें
JP Morgan Maintains Overweight on Cigna Group, Lowers Price Target to $375
Analyst Upgrades

Barclays Maintains Overweight on Cigna Group, Lowers Price Target to $300

Barclays analyst Andrew Mok maintains Cigna Group with a Overweight and lowers the price target from $383 to $300.

और देखें
Barclays Maintains Overweight on Cigna Group, Lowers Price Target to $300
Reuters

Health insurer Cigna beats quarterly profit estimates on health services strength

Cigna Group beat Wall Street estimates for third-quarter profit on Thursday, driven by strength in the company's health services unit Evernorth that houses its pharmacy benefit management business.

PR Newswire

Evernorth Announces New Era of Pharmacy Benefit Services to Lower Americans' Medication Costs

Evernorth, the health services division of The Cigna Group (NYSE:CI) today announced a new rebate-free pharmacy benefit model designed to help...

AI भविष्यवाणीBeta

AI सिफारिश

तेजी

पर अपडेट किया गया: 5 नव॰ 2025, 05:51 am

मंदीतटस्थतेजी

68.6% आत्मविश्वास

जोखिम और ट्रेडिंग

जोखिम स्तर1/5
कम जोखिम
के लिए उपयुक्त
रूढ़िवादीमूल्य
ट्रेडिंग गाइड

प्रवेश बिंदु

$244.87

लाभ लें

$249.29

स्टॉप लॉस

$219.96

मुख्य कारक

पीडीआई 7.0 एडीएक्स 11.9 के साथ एमडीआई 6.9 से ऊपर है, जो तेजी की प्रवृत्ति का सुझाव देता है
ट्रेडिंग वॉल्यूम औसत (20,150) का 12.7 गुना है, जो बेहद मजबूत खरीदारी दबाव का संकेत देता है
एमएसीडी 0.2199 सिग्नल लाइन 0.2029 से ऊपर है, जो तेजी के क्रॉसओवर का संकेत देता है

अपडेट रहें

मूल्य अलर्ट सेट करें, AI विश्लेषण अपडेट और वास्तविक समय बाजार समाचार प्राप्त करें।